Blood cancers, Myeloma
Results
Phase 2
This trial looked at a radiolabelled monoclonal antibody for people with myeloma. It was for people having high dose chemotherapy, followed by treatment with their own blood stem cells (autologous stem cell transplant).
Recruitment start: 18 December 2007
Recruitment end: 31 October 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kim Orchard
Bloodwise
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University Hospital Southampton NHS Foundation Trust
Southampton Clinical Trials Unit (University of Southampton)
Last reviewed: 10 December 2015
CRUK internal database number: 1621
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
